选择性雌激素受体调节剂研究现状  

Research progress on the selective estrogen receptor modulators

作　　者：丁浩[1] 杨帆[1,2] 蔡艺[1,2] 柴晓云[1] 吴秋业[1] 

机构地区：[1]第二军医大学药学院有机化学教研室,上海200433 [2]烟台大学药学院,山东烟台264005

出　　处：《药学实践杂志》2016年第1期1-4,55,共5页Journal of Pharmaceutical Practice

摘　　要：乳腺癌已经成为危害女性健康的主要恶性肿瘤,选择性雌激素受体调节剂作为治疗乳腺癌的有效药物越来越受到人们的广泛关注。笔者对选择性雌激素受体调节剂的研究现状进行综述。Breast cancer has become the main malignant tumors which pose a serious threat to women＇s health. Selective estrogen receptor modulators, which served as the effective drug treatment, have been attracting more attention. Present re- search progress on the selective estrogen receptor modulators was summarized in this paper.

关 键 词：雌激素 雌激素受体 选择性雌激素受体调节剂 

分 类 号：R977.1[医药卫生—药品]